BusinessPetMed Express, Inc. D/B/A 1-800-PETMEDS Announces Its Financial Results for Fiscal 2017 and Its Quarterly Dividend Raised to $0.20 Per ShareBy Nasdaq OMXMay 8, 2017, 12:01 PM UTC
BusinessFibrocell Announces Data Safety Monitoring Board Recommends Continuation of Phase 1/2 Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaBy Nasdaq OMXMay 8, 2017, 12:00 PM UTC
BusinessNewLink Genetics to Participate in Upcoming Investor ConferencesBy Nasdaq OMXMay 8, 2017, 11:00 AM UTC
BusinessAvid Runner Creates 50+ Member Team to Support Ovarian Cancer After Battling the DiseaseBy Nasdaq OMXMay 5, 2017, 6:58 PM UTC
BusinessBioSig Technologies to Present at Heart Rhythm Society’s Scientific Sessions on May 11 in ChicagoBy Nasdaq OMXMay 5, 2017, 12:00 PM UTC
BusinessMyriad Genetics to Present Results from Four Studies at the American Urological Association 2017 Annual MeetingBy Nasdaq OMXMay 5, 2017, 11:05 AM UTC
BusinessNewLink Genetics Reports First Quarter 2017 Financial Results and Updates Clinical Trial GuidanceBy Nasdaq OMXMay 4, 2017, 12:01 PM UTC
BusinessApricus Biosciences Announces the Initiation of Vitaros Drug-Device Human Factors StudyBy Nasdaq OMXMay 4, 2017, 11:01 AM UTC
